argenx SE (ARGX) Revenue History
Annual and quarterly revenue from 2011 to present
ARGX Revenue Over Time (2011–2025)
ARGX Revenue Growth History
11 of 14 years with positive growth- FY2011 revenue growth
- N/A
- FY2012 revenue growth
- +49.7%
- FY2013 revenue growth
- +69.4%
- FY2014 revenue growth
- +23.5%
- FY2015 revenue growth
- +64.1%
- FY2016 revenue growth
- +106.5%
- FY2017 revenue growth
- +182.3%
- FY2018 revenue growth
- -43.8%
- FY2019 revenue growth
- +219.3%
- FY2020 revenue growth
- -47.4%
- FY2021 revenue growth
- +1105.7%
- FY2022 revenue growth
- -17.4%
- FY2023 revenue growth
- +198.6%
- FY2024 revenue growth
- +78.6%
- FY2025 revenue growth
- +89.6%
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $1.30B | -3.6% |
| Q2 2025 | $948.0M | +5.1% |
| Q4 2024 | $1.35B | +77.7% |
| Q2 2024 | $901.9M | +92.6% |
| Q4 2023 | $757.7M | +150.1% |
| Q2 2023 | $468.2M | +320.5% |
| Q4 2022 | $302.9M | +1063.3% |
| Q2 2022 | $111.4M | -73.5% |
Revenue Breakdown
ARGX's revenue distribution by segment and geography
By Geography
ARGX Revenue Analysis (2011–2025)
Current Revenue & Growth
As of June 23, 2026, argenx SE (ARGX) generated trailing twelve-month (TTM) revenue of $4.49 billion, reflecting slight decline in growth of -3.6% year-over-year. The most recent quarter (Q4 2025) recorded $1.30 billion in revenue, up 36.9% sequentially.
Historical Growth Trajectory
ARGX's 5-year compound annual growth rate (CAGR) stands at +151.5%, indicating outstanding long-term growth trajectory. The 3-year CAGR of +116.2% is below the 5-year average, signalling a growth deceleration in recent years. argenx SE's highest annual revenue of $4.15 billion was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including RARE (+13.3% YoY), ALNY (+82.6% YoY), and SRPT (-2.2% YoY) — ARGX has underperformed the peer group in revenue growth. Compare ARGX vs RARE →
ARGX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ARGXCurrent | $4.5B | -3.6% | +151.5% | 25.4% | |
 RARE | $673M | +13.3% | +19.9% | -79.5% | |
 ALNY | $3.7B | +82.6% | +49.8% | 13.5% | |
 SRPT | $2.2B | -2.2% | +32.4% | -29.9% | |
 BMRN | $3.2B | +9.9% | +11.6% | 16.6% | |
 IONS | $944M | +47.5% | +5.3% | -40.5% |
ARGX Historical Revenue Data (2011–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4.15B | +89.6% | $3.70B | 89.1% | $1.05B | 25.4% |
| 2024 | $2.19B | +78.6% | $1.96B | 89.6% | $-21,654,000 | -1.0% |
| 2023 | $1.23B | +198.6% | $1.11B | 90.4% | $-425,049,000 | -34.7% |
| 2022 | $410.7M | -17.4% | $381.3M | 92.8% | $-720,341,000 | -175.4% |
| 2021 | $497.3M | +1105.7% | $497.3M | 100.0% | $-348,746,000 | -70.1% |
| 2020 | $41.2M | -47.4% | $41.2M | 100.0% | $-477,617,000 | -1158.1% |
| 2019 | $78.5M | +219.3% | $78.5M | 100.0% | $-198,892,000 | -253.5% |
| 2018 | $24.6M | -43.8% | $24.6M | 100.0% | $-93,627,000 | -381.0% |
| 2017 | $43.7M | +182.3% | $43.7M | 100.0% | $-27,512,000 | -63.0% |
| 2016 | $15.5M | +106.5% | $15.5M | 100.0% | $-22,523,000 | -145.6% |
| 2015 | $7.5M | +64.1% | $7.5M | 100.0% | $-17,061,000 | -227.7% |
| 2014 | $4.6M | +23.5% | $4.6M | 100.0% | $-13,064,000 | -286.1% |
| 2013 | $3.7M | +69.4% | $2.7M | 72.4% | $-8,603,000 | -232.7% |
| 2012 | $2.2M | +49.7% | $2.2M | 100.0% | $-13,293,000 | -608.9% |
| 2011 | $1.5M | - | $1.5M | 100.0% | $-4,718,000 | -323.6% |
Full Stock Analysis
Deep dive into ARGX consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
15+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ARGX — Frequently Asked Questions
Quick answers to the most common questions about buying ARGX stock.
Is ARGX's revenue growth accelerating or slowing?
ARGX revenue growth is slowing. TTM revenue is $4.5B, up -3.6% year-over-year — below the 5-year CAGR of +151.5%. The deceleration suggests maturing end-markets or increased competition.
What is ARGX's revenue history from 2011 to 2026?
argenx SE (ARGX) revenue history spans 2011 to 2026. TTM revenue as of 2026 is $4.5B, growing at -3.6% YoY. The 5-year CAGR is +151.5%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is ARGX's long-term revenue growth rate (CAGR)?
argenx SE's 5-year revenue CAGR of +151.5% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -3.6% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for ARGX.
Why does ARGX's quarterly revenue fluctuate?
ARGX quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. argenx SE's revenue data from 2011 to 2026 shows full historical quarterly detail on this page.
How is ARGX's revenue distributed by segment?
ARGX reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does ARGX's revenue compare to industry peers?
argenx SE (ARGX) with TTM revenue of $4.5B and -3.6% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.